Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Finance
  • Yacht Buyer
  • Banking
  • Stocks
  • Nyse
  • Loans
ncarol.com

Certified Nutraceuticals Partners with Colorado Researchers for Groundbreaking Study on KollaJell™ and Brain Health
ncarol.com/10282619

Trending...
  • François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
  • Off The Hook YS (NY SE: OTH) Executes Transformational Apex Acquisition, Creating Vertically Integrated Marine Powerhouse with $60M Inventory Capacity
Certified Nutraceuticals, Inc.
The study aims to validate KollaJell™ as the first and only collagen-based brain health product backed by clinical trials.

TEMECULA, Calif. - ncarol.com -- Temecula, CA—Certified Nutraceuticals Inc. announced the start of a clinical study on the cognitive benefits of KollaJell™, a patented jellyfish collagen supplement uniquely formulated to support brain health. The study aims to validate KollaJell™ as the first and only collagen-based brain health product backed by clinical trials.

The innovative study will utilize advanced brain imaging technologies, including electroencephalographic (EEG) scans, to measure cognitive function and brain activity before and after KollaJell™ supplementation. The project also utilizes computerized cognitive assessments to evaluate critical mental performance domains such as memory and multitasking. Results of this unique investigation are anticipated by April 2025 and will be published in peer-reviewed scientific journals.

The research team consists of Dr. G.M. Haase, who has developed numerous innovations in nutritional science, holds 12 U.S. patents, and has published 200 research papers. Neil Wolkodoff, Ph.D., is the Medical Program Director of the Colorado Center for Health and Sport Science and is an expert in health and performance metrics.

More on ncarol.com
  • Dr. Nadene Rose Releases Moving Memoir on Faith, Grief, and Divine Presence
  • Gigasoft Solves AI's Biggest Charting Code Problem: Hallucinated Property Names
  • Akg To Demonstrate New Digital E-catalog Experience Daily At Conexpo-con/agg 2026
  • ASTI Ignites the Space Economy: Powering SpaceX's NOVI AI Pathfinder with Breakthrough Solar Technology: Ascent Solar Technologies (N A S D A Q: ASTI)
  • STEM For Kids Launches Root Protocol™: A Human Bridge for Gen Alpha's Digital Curiosity Crisis

Abdul Alkayali, Senior Vice President of Certified Nutraceuticals noted, "CN has been at the forefront of nutritional innovation, with KollaJell™ standing as a testament to our commitment to science-backed health solutions. This clinical study represents a significant step toward establishing KollaJell™ as the only brain health supplement with academic-led clinical validation. The study will solidify the product's credibility and enhance our global market presence."

About Certified Nutraceuticals

Certified Nutraceuticals develops natural, functional, ingredient-based compounds that promote healthy and active lifestyles. Products are rooted in traditional medicine and validated by modern science and impact anti-aging on a cellular level, joint, brain, cardiovascular, and immune health.

Learn more at www.certifiednutra.com

Media Contact: Sara Alkayali, 951-600-3899.  Email: salkayali@certifiednutra.com

Media Contact
Abdul Alkayali
asalkayali@certifiednutra.com
951-600-3899


Source: Certified Nutraceuticals

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • $38 Million in U.S. Government Contract Awards Secured Through Strategic Partner. Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
  • Mecpow M1: A Safe & Affordable Laser Engraver Built for Home DIY Beginners
  • CrashStory.com Launches First Colorado Crash Data Platform Built for Victims, Not Lawyers
  • Inkdnylon Earns BBB Accreditation for Verified Business Integrity
  • Josh Stout "The Western Project"
  • Open House Momentum Builds at Heritage at South Brunswick
  • A Celebration of Visibility, Voice and Excellence: The 57th NAACP Image Awards Golf Invitational, Presented by Wells Fargo, A PGD Global Production
  • Athens in Spring: A Culinary City Break That Rivals Paris and Copenhagen
  • ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership
  • Jayne Williams Joins Century Fasteners Corp. Sales and Business Development Team
  • Rocket Fibre Services Growing Customer Base With netElastic Networking Software
  • Cummings Graduate Institute for Behavioral Health Studies Honors New Doctor of Behavioral Health Graduates
  • IDpack v4 Launches: A Major Evolution in Cloud-Based ID Card Issuance
  • CCHR Says Psychiatry's Admission on Antidepressant Withdrawal Comes Far Too Late
  • 505 Plumbing, Heating & Cooling Launches in Albuquerque, Bringing a Customer-First Approach to Home Services
  • As AI.com Sells For Record $70 Million, Attention Now Turns To ArtificialIntelligence.com
  • AOW Event Sponsored By The Stanglwirt Resort a renowned five-star Austrian wellness destination
  • Average US gambler spends $210 per month in 2026
  • 10X Recruitment Launches Operator-Led Executive Search for Behavioral Health and Legal Leaders
  • Integris Composites developing armor for military in Arctic Circle
_catLbl0 _catLbl1

Popular on ncarol.com

  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies - 108
  • Desert Mountain Club Earns Prestigious Blue Zones Approved™ Triple Designation, a New Standard for Well-Being in a Luxury Lifestyle Community - 106
  • HELM Audio™ Partners with PQCrypto to Future-Proof Children's Hearing and Safety Data Using Post-Quantum Cryptography
  • Postmortem Pathology Expands to Phoenix: Bringing Families Answers During Their Most Difficult Moments
  • Blasting Off with Space Sector Companies: Artemis II Manned Moon Mission is Set to Launch: Could $ASTI be on the Same Rocket Ride as $ASTS & $LUNR?
  • CNCPW Divulga Dados de Liquidez do 1º Trimestre: Confirma 100% de Reservas e Atualiza Protocolos de "Saque CNCPW" Contra Fluxos Ilícitos
  • purelyIV Expands Concierge Wellness Platform with New IV Therapies, Memberships, and Digital Experience
  • CCHR: Europe Rejects Forced Psychiatry—Landmark Vote Declares Coercive Practices Incompatible with Human Rights
  • Still Using Ice? FrostSkin Reinvents Hydration
  • Wall Street Is Missing This One: Cycurion (NAS DAQ: CYCU) Gets $7 Price Target While Trading at a Steep Discount

Similar on ncarol.com

  • ClearSight Therapeutics Signs LOI with Covalent Medical for $60M Multi-Channel OTC Eye Care Partnership
  • Cummings Graduate Institute for Behavioral Health Studies Honors New Doctor of Behavioral Health Graduates
  • IDpack v4 Launches: A Major Evolution in Cloud-Based ID Card Issuance
  • CCHR Says Psychiatry's Admission on Antidepressant Withdrawal Comes Far Too Late
  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
  • Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
  • Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute